Marshall Wace
MKUL

Marshall Wace’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Marshall Wace’s Portfolio MKUL Stock Details MKUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-53,100
Closed -$696K – 3939
2022
Q2 		$696K Buy
+53,100
New +$313K ﹤0.01% 2639

Other funds holding MKUL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's MKUL Position: Q3 2022 in Review

Marshall Wace sold out of Molekule Group, Inc. Common Stock (MKUL) in Q3 2022, closing a stake of 53,100 shares — an estimated $696K sold.

Marshall Wace first reported a position in MKUL in Q2 2022 and held it in 1 quarter. The position peaked at $696K in Q2 2022. 17 funds tracked by Wall St. Rank hold MKUL as of Q3 2022.

  • Marshall Wace reported no remaining Molekule Group, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 53,100 Molekule Group, Inc. Common Stock shares in Q3 2022, an estimated $696K.
  • Marshall Wace first reported a position in Molekule Group, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Marshall Wace's Molekule Group, Inc. Common Stock position peaked at $696K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.